drug discovery

Agilent, Molecular Discovery Partner on Drug Development

The two companies have joined forces to provide researchers with an advanced metabolite-identification platform.

Agilent Technologies Inc. today announced that it has entered into a comarketing agreement with Molecular Discovery Ltd. to provide biopharmaceutical researchers with an advanced metabolite-identification platform. The companies will comarket the combined assets of Agilent's high-resolution liquid chromatography/mass spectrometry (LC/MS) technology and Molecular Discovery's Mass-MetaSite software to enable superior identification and analysis of complex biological mixtures.

No votes yet

Lilly, AMRI Collaborate For In-Sourced Chemistry Services

AMRI, Albany, NY, announced that, as part of a new collaboration agreement with Eli Lilly, it anticipates hiring more than 40 synthetic chemists by the third quarter of 2012 to support Lilly’s drug discovery programs.
The chemists will work onsite at Lilly’s headquarters in Indianapolis, Indiana, where they will support the medicinal chemistry department.
Syndicate content